Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Liminal BioSciences Inc.
LMNL
Healthcare
Biotechnology
Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed...
for trading on the Nasdaq Global Market.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:LMNL)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(40)
•••
balain
X
View Profile
View Bullboard History
Post by
balain
on Mar 23, 2022 9:31pm
crappot, check your inbox
EOM
(10)
•••
riskybznz
X
View Profile
View Bullboard History
Comment by
riskybznz
on Mar 23, 2022 8:56pm
RE:RE:Liminal Biosciences Reports Q4 and Year end 2021 Results
https://investors.liminalbiosciences.com/Financial-Reports-2021 I guess Q4 hasn't been posted yet... /[Shrug]\
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(40)
•••
balain
X
View Profile
View Bullboard History
Post by
balain
on Mar 23, 2022 7:46pm
CRAPPOT... Pierre Laurin - Fire - Prometic - Bob McWhirter
Hey crappot! I'll take any dirt you have on Laurin, the fires, Prometic, and McWhirter and his pump and dump if you have any? Anything that may corraborate rumours of wrong doing would help
...more
(74)
•••
GunnerG
X
View Profile
View Bullboard History
Comment by
GunnerG
on Mar 22, 2022 5:15pm
RE:Liminal Biosciences Reports Q4 and Year end 2021 Results
This is the News Release. I am looking for the Financial Statements.
(77)
•••
crappot
X
View Profile
View Bullboard History
Post by
crappot
on Mar 22, 2022 2:47pm
LOL THE LOOSERS ARE PUMPING...
TO GET IT OVER A BUCK, THEY SHOULD ALL BE SENT TO RUSSIA TO LIVE & I WILL BURN DOWN THEIR HOUSE AGAIN....
(10)
•••
riskybznz
X
View Profile
View Bullboard History
Post by
riskybznz
on Mar 21, 2022 9:08pm
Liminal Biosciences Reports Q4 and Year end 2021 Results
https://investors.liminalbiosciences.com/2022-03-17-Liminal-BioSciences-Reports-Fourth-Quarter-and-Year-End-2021-Financial-Results
(74)
•••
GunnerG
X
View Profile
View Bullboard History
Post by
GunnerG
on Mar 21, 2022 3:37pm
where are Q4 2021 FS
Anyone have a link?
(74)
•••
GunnerG
X
View Profile
View Bullboard History
Comment by
GunnerG
on Mar 20, 2022 9:38am
RE:Ryplazim
Hopefully it works better than your link. Happy for the patients though.
(529)
•••
Dibah420
X
View Profile
View Bullboard History
Post by
Dibah420
on Mar 20, 2022 8:01am
Ryplazim
https://www.facebook.com/photo/?fbid=10158498929366179&set=gm.4948556028554752 First commercially produced Ryplazim from Kedrion arrives in the hands of patients suffering from PG
...more
(529)
•••
Dibah420
X
View Profile
View Bullboard History
Post by
Dibah420
on Mar 18, 2022 12:30pm
Mitts vs the shorts
Remember black mamba, seeking alpha, muddy waters, carson block etc etc? Here's an interesting piece: How a Columbia professor became the scourge of activist short sellers
...more
(529)
•••
Dibah420
X
View Profile
View Bullboard History
Post by
Dibah420
on Mar 18, 2022 9:17am
Lots of headfakes today
But pre mkt can't get more than 8 bids! LIMINAL BIOSCIENCES INC (US: LMNL)
...more
(2)
•••
37minus4
X
View Profile
View Bullboard History
Comment by
37minus4
on Mar 17, 2022 8:33am
RE:RE:RE:RE:RE:Patent update
^^^^ And there is the answer ^^^^ :-P 33
(6)
•••
edrose
X
View Profile
View Bullboard History
Post by
edrose
on Mar 16, 2022 8:46pm
Please elaborate about 2018 deal that was on table
For retail investors
(3)
•••
PLIImfoservice
X
View Profile
View Bullboard History
Comment by
PLIImfoservice
on Mar 16, 2022 3:01pm
RE:RE:RE:RE:Patent update
Those kcoc srekcus have to be dealt with imho
(10)
•••
stockbuphoon
X
View Profile
View Bullboard History
Comment by
stockbuphoon
on Mar 16, 2022 12:01pm
RE:RE:RE:Patent update
Management and Thomvest are doing everything they can to get it delisted. It's an easily telegraphed plan. Thomvest knew the offers on table in 2018 and they pulled off the financial engineering
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden